ArticleJCI insight2019

Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients.

Kazushiro Takata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.